EG Capital Group

Presto is a hospitality technology company that overlays digital solutions onto the physical world to automate restaurant operations and enhance guest experiences. Its enterprise-grade voice, vision, and touch technologies support drive-thru automation, on-demand delivery management, and labor optimization for hospitality businesses. Having shipped over 250,000 systems, Presto ranks among the leading labor automation providers in the industry and serves major U.S. restaurant brands. Founded at MIT in 2008, the company is headquartered in Silicon Valley, California, and generates most of its revenue in the United States.

C4 Therapeutics is a biopharmaceutical company developing targeted protein degradation therapies using its proprietary Degronimid platform. This platform enables the selective destruction of disease-causing proteins, expanding the scope of treatable conditions and potentially reducing drug resistance. The company focuses on oncology indications and has strategic collaborations with industry leaders.